Early Weight Loss Linked to Lower Gastroesophageal Junction Carcinoma Survival Rates
source: pixabay.com

Early Weight Loss Linked to Lower Gastroesophageal Junction Carcinoma Survival Rates

Unintended weight loss is a symptom associated with many different forms of cancer. But what can this weight loss tell researchers about the patients and their outcomes? Healio shares a…

Continue Reading Early Weight Loss Linked to Lower Gastroesophageal Junction Carcinoma Survival Rates

Study of the Week: Early GI Cancer Screening is Recommended for Primary Immunodeficiency Patients

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

Continue Reading Study of the Week: Early GI Cancer Screening is Recommended for Primary Immunodeficiency Patients

 A Clinical Trial Confirms That Nivolumab Plus Chemotherapy Outperforms Immunotherapy Alone In Gastric Cancer Treatment

Healio recently published results of the CheckMate 649 study confirming the benefits of combining nivolumab and chemotherapy in treating newly diagnosed patients with gastroesophageal junction cancer and advanced gastric and…

Continue Reading  A Clinical Trial Confirms That Nivolumab Plus Chemotherapy Outperforms Immunotherapy Alone In Gastric Cancer Treatment

Will Nivolumab Combined with Chemotherapy be the New Star in Controlling Advanced Gastric Cancer?

Platinum-based chemotherapy has been the standard treatment for patients with metastatic gastric adenocarcinoma for over ten years. According to a recent article in Healio, the median survival is about nine…

Continue Reading Will Nivolumab Combined with Chemotherapy be the New Star in Controlling Advanced Gastric Cancer?